Ensuring Quality Data in Indian Clinical Trials
Author Information
Author(s): Hajos Antal K., Kamble Sujal K.
Primary Institution: Procelsis Consulting, Germany
Hypothesis
How can quality and compliance be ensured in clinical trials conducted in India?
Conclusion
A structured approach using the PDCA cycle can enhance the quality of clinical trial data and site functioning in India.
Supporting Evidence
- Quality management systems are essential for conducting clinical trials.
- The PDCA cycle helps structure key steps in ensuring data quality.
- India is a rapidly growing market for clinical trials but faces challenges in quality management.
Takeaway
This study talks about how to make sure that clinical trials in India collect good data by following a simple plan. It’s like making sure you have all your toys in order before playing.
Methodology
The study uses the PDCA cycle to structure the processes of clinical trials from protocol to final analysis.
Potential Biases
Potential biases may arise from the lack of experienced personnel and infrastructure in rapidly growing clinical trial markets.
Limitations
The study does not provide specific data on the effectiveness of the proposed strategies.
Participant Demographics
The study focuses on clinical trial sites in India, which are characterized by a mix of experienced and inexperienced personnel.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website